Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 976 to 1000 of 2526

TitleReference numberPublishedLast updated
Transcranial magnetic stimulation for auditory hallucinationsIPG680
Novii Wireless Patch System for maternal and fetal monitoringMIB228
Polatuzumab vedotin with rituximab and bendamustine for treating relapsed or refractory diffuse large B-cell lymphomaTA649
Neuropathic pain in adults: pharmacological management in non-specialist settingsCG173
t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetesMIB227
Insect bites and stings: antimicrobial prescribingNG182
Dupilumab for treating chronic rhinosinusitis with nasal polyps (terminated appraisal)TA648
Axonics sacral neuromodulation system for treating refractory overactive bladderHTG554
Implantable cardiac monitors to detect atrial fibrillation after cryptogenic strokeHTG553
Avelumab with axitinib for untreated advanced renal cell carcinomaTA645
Glasdegib with chemotherapy for untreated acute myeloid leukaemia (terminated appraisal)TA646
Eculizumab for treating relapsing neuromyelitis optica (terminated appraisal)TA647
Helge for detecting haemolysisMIB225
Community pharmacies: promoting health and wellbeingQS196
Faltering growthQS197
High-sensitivity troponin tests for the early rule out of NSTEMIHTG552
FebriDx for C-reactive protein and myxovirus resistance protein A testingMIB224
Anaphylaxis: assessment and referral after emergency treatmentCG134
Perioperative care in adultsNG180
Rehabilitation for adults with complex psychosisNG181
Surgical site infections: prevention and treatmentNG125
Deep brain stimulation for refractory epilepsy in adultsIPG678
Implanted vagus nerve stimulation for treatment-resistant depressionIPG679
Entrectinib for treating ROS1-positive advanced non-small-cell lung cancerTA643
Entrectinib for treating NTRK fusion-positive solid tumoursTA644

Results per page

  1. 10
  2. 25
  3. 50
  4. All